CGHMC's Heart Institute Performs the 1st Successful Percutaneous Mitral Valve Repair (MitraClip)

Dr. James G. Dy, President of the Chinese General Hospital & Medical Center is proud to announce that on November 26, 2014, a team of physicians composed of Dr. Timothy C. Dy, Dr. Melissa Co-Sia, Dr. Aristides Panlilio, and Dr. Theresa Menor performed the country's first clinically successful non-surgical repair of the mitral valve (MitraClip) at Chinese General Hospital and Medical Center's (CGHMC) Cardiovascular Catherization and Intervention Unit (CCIU). Dr. Timothy C. Dy, who currently serves as the Assistant Chairman of the Department of Internal Medicine and the Assistant Head of its CCIU, performed the procedure with the assistance of Dr. Magnus Settergren, an international expert on MitraClip. Dr. Settergren is currently Director of Interventional Cardiology at Karolinska University Hospital in Stockholm, Sweden.

This breakthrough procedure represents the next advancement in non-surgical treatment of valvular heart disease. In March of 2012, the same team, with Dr. Nelson Lee, performed their first Transcatheter Aortic Valve Replacement (TAVR) at CGHMC. TAVR addresses a problem in the aortic valve called aortic stenosis, which impedes the flow of blood from the heart to the rest of the body. The team has performed 16 TAVR cases since 2012.

MitraClip aims to address another common valvular problem, mitral valve regurgitation. This is a condition where blood that has already entered the heart flows backwards towards the lungs instead of being sent out to the rest of the body. Just like aortic stenosis, mitral regurgitation can affect many different patients. The mainstream treatment for severe aortic and mitral valvular disease is open-heart surgery. However, up to 30% of patients who needs surgery are deemed too high-risk to undergo an operation.

Percutaneous (non-surgical) therapy for valvular problems represents a revolutionary option for patients who would otherwise not receive any treatment. Studies comparing these treatment modalities against surgery have shown that in carefully-screened and selected patients, these less-invasive treatments have outcomes that are just as good as or better than surgery. Even in high-risk patients who are no longer surgical candidates, these procedures can be performed with a high level of safety and success. Patients spend less time in the intensive care unit (ICU) during recovery and generally can be sent home much earlier than patients undergoing open-heart surgery. Their recuperation after discharge from the hospital is likewise shorter.

Given the less-invasive nature of the MitraClip procedure, it will likely be made available to patients who are at lower risk for surgery in the future. Such developments are already seen with TAVR, which is approved for use even in patients who are in acceptable, but high surgical risk.

The Heart Insititute at CGHMC was established in 1996 to address the ever-changing cardiovascular needs of patients. CGHMC is proud to announce that as of this writing, in addition to their ongoing successful TAVR program, it is the only hospital in the country to have had a clinically successful percutaneous repair of mitral regurgitation. This success builds on a long tradition of CGHMC physicians providing state-of-the-art treatment to patients even before the Heart Institute was established, beginning with the country's first His-bundle electronic cardiogram in 1970, the first balloon atrial septostomy in1971 both by Dr. Bun Yok Dy, the first ventricular aneursymectomy by Dr. Manuel Tayao in 1971, the first renal, iliac, and femoral stenting bin 1998 by Dr. Bun Yok Dy, one of the first EndoVascular Aneurysm Reparis (EVAR) in 2000, the first carotid stenting with distal embolic protection in 2000, and the first bi-ventricular pacing for congestive heart failure in 2002; by the father and son team of Dr. Bun Yok Dy and Dr. Timothy Dy. Today, the Heart Institute offers what would arguably be the country's most comprehensive diagnostic and therapeutic cardiovascular procedure for patients.

The Chinese General Hospital & Medical Center, which is owned and operated by the Philippine Chinese Charitable Association, Inc., has also been recently awarded ISO 9001:2008 Certification (Certificate No. AJA 14.0815).

This recent development is a continuation of Chinese General Hospital and Medical Center's proud tradition of pioneering excellence in health care management particularly in the field of cardiovascular intervention.